Sunshine Act Notice: Cancellation of Meeting Notice, 5114 [2015-01921]
Download as PDF
<![CDATA[
5114
Federal Register / Vol. 80, No. 20 / Friday, January 30, 2015 / Notices
Consumer & Governmental Affairs
Bureau at (202) 418–0530 (voice), (202)
418–0432 (TTY). Such requests should
include a detailed description of the
accommodation needed. In addition,
please include a way the FCC can
contact you if it needs more
information. Please allow at least five
days’ advance notice; last-minute
requests will be accepted, but may be
impossible to fill.
Federal Communications Commission.
Sheryl D. Todd,
Deputy Secretary.
[FR Doc. 2015–01811 Filed 1–29–15; 8:45 am]
BILLING CODE 6712–01–P
FEDERAL MINE SAFETY AND HEALTH
REVIEW COMMISSION
Sunshine Act Notice: Cancellation of
Meeting Notice
January 28, 2015.
The following Commission meeting
has been cancelled. No earlier
announcement of the cancellation was
possible.
2:00 p.m., Thursday,
January 29, 2015.
TIME AND DATE:
The Richard V. Backley Hearing
Room, Room 511N, 1331 Pennsylvania
Avenue NW., Washington, DC 20004
(enter from F Street entrance).
PLACE:
STATUS:
Closed.
It was
determined by a unanimous vote of the
Commissioners that the Commission
consider and act upon the following in
closed session: Brody Mining, LLC v.
Secretary of Labor, Docket Nos. WEVA
2014–82–R, et al. (Issues include
whether to grant the Secretary of Labor’s
Emergency Motion for Stay of ALJ’s
Order Dismissing Pattern-of-Violations
Notice.)
Any person attending this meeting
who requires special accessibility
features and/or auxiliary aids, such as
sign language interpreters, must inform
the Commission in advance of those
needs. Subject to 29 CFR 2706.150(a)(3)
and § 2706.160(d).
asabaliauskas on DSK5VPTVN1PROD with NOTICES
MATTERS TO BE CONSIDERED:
CONTACT PERSON FOR MORE INFO:
Emogene Johnson (202) 434–9935/(202)
708–9300 for TDD Relay/1–800–877–
8339 for toll free.
Sarah L. Stewart,
Deputy General Counsel.
[FR Doc. 2015–01921 Filed 1–28–15; 4:15 pm]
BILLING CODE 6735–01–P
VerDate Sep<11>2014
18:50 Jan 29, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–15–1019]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. To request more
information on the below proposed
project or to obtain a copy of the
information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy A. Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
Integrating Community Pharmacists
and Clinical Sites for Patient-Centered
HIV Care (OMB No. 0920–1019, expires
05/31/2017)—Revision—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Medication Therapy Management
(MTM) is a group of pharmacist
provided services that is independent
of, but can occur in conjunction with,
provision of medication. MTM
encompasses a broad range of
professional activities and cognitive
services within the licensed
pharmacists’ scope of practice and can
include monitoring prescription filling
patterns and timing of refills, checking
for medication interactions, patient
education, and monitoring of patient
response to drug therapy.
HIV specific MTM programs have
demonstrated success in improving HIV
medication therapy adherence and
persistence. While MTM programs have
been shown to be effective in increasing
medication adherence for HIV-infected
persons, no MTM programs have been
expanded to incorporate primary
medical providers in an effort to
establish patient-centered HIV care. To
address this problem CDC has entered
into a public-private partnership with
Walgreen Company (a.k.a Walgreens
pharmacies, a national retail pharmacy
chain) to develop and implement a
model of HIV care that integrates
community pharmacists with primary
medical providers for patient-centered
HIV care. The model program will be
implemented in ten sites and will
provide patient-centered HIV care for
approximately 1,000 persons.
The patient-centered HIV care model
will include the core elements of MTM
as well as additional services such as
individualized medication adherence
counseling, active monitoring of
prescription refills and active
collaboration between pharmacists and
medical clinic providers to identify and
resolve medication related treatment
problems such as treatment
effectiveness, adverse events and poor
adherence. The expected outcomes of
the model program are increased
retention in HIV care, adherence to HIV
medication therapy and viral load
suppression.
On 16 May 2014, OMB approved the
collection of standardized information
from ten project sites over the three-year
E:\FR\FM\30JAN1.SGM
30JAN1
]]>Agencies
[Federal Register Volume 80, Number 20 (Friday, January 30, 2015)]
[Notices]
[Page 5114]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01921]
=======================================================================
-----------------------------------------------------------------------
FEDERAL MINE SAFETY AND HEALTH REVIEW COMMISSION
Sunshine Act Notice: Cancellation of Meeting Notice
January 28, 2015.
The following Commission meeting has been cancelled. No earlier
announcement of the cancellation was possible.
TIME AND DATE: 2:00 p.m., Thursday, January 29, 2015.
PLACE: The Richard V. Backley Hearing Room, Room 511N, 1331
Pennsylvania Avenue NW., Washington, DC 20004 (enter from F Street
entrance).
STATUS: Closed.
MATTERS TO BE CONSIDERED: It was determined by a unanimous vote of the
Commissioners that the Commission consider and act upon the following
in closed session: Brody Mining, LLC v. Secretary of Labor, Docket Nos.
WEVA 2014-82-R, et al. (Issues include whether to grant the Secretary
of Labor's Emergency Motion for Stay of ALJ's Order Dismissing Pattern-
of-Violations Notice.)
Any person attending this meeting who requires special
accessibility features and/or auxiliary aids, such as sign language
interpreters, must inform the Commission in advance of those needs.
Subject to 29 CFR 2706.150(a)(3) and Sec. 2706.160(d).
CONTACT PERSON FOR MORE INFO: Emogene Johnson (202) 434-9935/(202) 708-
9300 for TDD Relay/1-800-877-8339 for toll free.
Sarah L. Stewart,
Deputy General Counsel.
[FR Doc. 2015-01921 Filed 1-28-15; 4:15 pm]
BILLING CODE 6735-01-P
